tiprankstipranks
Annovis Bio (ANVS)
NYSE:ANVS
US Market

Annovis Bio (ANVS) Financial Statements

Compare
604 Followers

Annovis Bio Financial Overview

Annovis Bio's market cap is currently $43.45M. The company's EPS TTM is $-3.85; its P/E ratio is ―; Annovis Bio is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -45.04M$ -25.51M$ -14.54M$ -6.64M$ -1.61M
EBITDA$ -45.04M$ 0.00$ 0.00$ 0.00$ 0.00
Net Income$ -56.20M$ -25.15M$ -14.44M$ -4.26M$ -296.84K
Balance Sheet
Cash & Short-Term Investments$ 5.75M$ 28.38M$ 45.69M$ 8.07M$ 1.86K
Total Assets$ 10.21M$ 36.02M$ 46.00M$ 8.12M$ 1.12M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 499.81K
Net Debt$ -5.75M$ -28.38M$ -45.69M$ -8.07M$ 497.95K
Total Liabilities$ 17.96M$ 7.70M$ 1.51M$ 578.38K$ 9.69M
Stockholders' Equity$ -7.75M$ 28.32M$ 44.49M$ 7.54M$ -8.58M
Cash Flow
Free Cash Flow$ -39.97M$ -17.31M$ -9.13M$ -3.97M$ -476.54K
Operating Cash Flow$ -39.97M$ -17.31M$ -9.13M$ -3.97M$ -476.54K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 17.34M$ 4.61K$ 46.74M$ 12.04M$ 443.09K
Currency in USD

Annovis Bio Earnings and Revenue History

Annovis Bio Debt to Assets

Annovis Bio Cash Flow

Annovis Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis